JEOL annual revenue was ¥111.29 b in FY 2019

JEOL Revenue growth (FY, 2018 - FY, 2019), %6%

JEOL Gross profit (FY, 2019)42.4 B

JEOL Gross profit margin (FY, 2019), %38.1%

JEOL Net income (FY, 2019)5.9 B

JEOL EBIT (FY, 2019)6.7 B

JEOL Cash, 31-Mar-20199.3 B

JEOL revenue was ¥111.29 b in FY, 2019 which is a 6.4% year over year increase from the previous period.

JEOL revenue breakdown by business segment: 18.5% from Medical Equipment, 16.0% from Industrial Equipment and 65.5% from Scientific Instruments

JEOL revenue breakdown by geographic segment: 43.2% from Japan, 17.4% from United States and 39.3% from Other

JPY | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Revenue | 99.7b | 104.6b | 111.3b |

| 5% | 6% | |

## Cost of goods sold | 64.8b | 67.1b | 68.9b |

## Gross profit | 34.9b | 37.5b | 42.4b |

| 35% | 36% | 38% |

## R&D expense | 6.1b | 6.0b | 7.2b |

## General and administrative expense | 27.5b | 26.5b | 28.6b |

## Operating expense total | 33.7b | 32.6b | 35.8b |

## Depreciation and amortization | 1.2b | 1.0b | |

## EBIT | 2.1b | 3.9b | 6.7b |

| 2% | 4% | 6% |

## Interest expense | 367.0m | 226.0m | 156.0m |

## Interest income | 163.0m | 188.0m | 26.0m |

## Pre tax profit | 2.3b | 4.8b | 7.5b |

## Income tax expense | 1.7b | 265.0m | 1.6b |

## Net Income | 596.0m | 4.5b | 5.9b |

JPY | H1, 2018 | H1, 2019 |
---|---|---|

## Revenue | 40.7b | 46.7b |

## Cost of goods sold | 26.0b | 28.4b |

## Gross profit | 14.7b | 18.3b |

| 36% | 39% |

## R&D expense | 2.7b | 3.4b |

## General and administrative expense | 13.3b | 14.0b |

## Operating expense total | 16.0b | 17.4b |

## EBIT | (1.3b) | 979.0m |

| (3%) | 2% |

## Interest expense | 113.0m | 75.0m |

## Interest income | 11.0m | 13.0m |

## Pre tax profit | (521.0m) | 1.8b |

## Income tax expense | 210.0m | 392.0m |

## Net Income | (731.0m) | 1.4b |

JPY | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Cash | 9.4b | 9.7b | 9.3b |

## Accounts Receivable | 23.2b | 28.0b | 32.4b |

## Prepaid Expenses | 2.3b | 2.2b | |

## Inventories | 39.3b | 41.4b | 48.6b |

## Current Assets | 80.1b | 86.1b | 93.2b |

## PP&E | 13.5b | 13.6b | 13.2b |

## Goodwill | 2.5b | 2.1b | 1.8b |

## Total Assets | 109.0b | 114.8b | 122.7b |

## Accounts Payable | 7.0b | 9.0b | 14.4b |

## Short-term debt | 12.3b | 10.6b | 10.7b |

## Current Liabilities | 47.1b | 53.0b | 60.1b |

## Long-term debt | 18.6b | 13.5b | 10.6b |

## Non-Current Liabilities | 29.6b | 24.4b | 21.0b |

## Total Debt | 30.9b | 24.1b | 21.3b |

## Total Liabilities | 76.8b | 77.4b | 81.1b |

## Common Stock | 10.0b | 10.0b | 10.0b |

## Additional Paid-in Capital | 9.4b | 9.4b | 9.9b |

## Retained Earnings | 14.0b | 17.8b | 22.9b |

## Total Equity | 32.3b | 37.4b | 41.8b |

## Debt to Equity Ratio | 1 x | 0.6 x | 0.5 x |

## Debt to Assets Ratio | 0.3 x | 0.2 x | 0.2 x |

## Financial Leverage | 3.4 x | 3.1 x | 2.9 x |

JPY | H1, 2018 | H1, 2019 |
---|---|---|

## Cash | 8.8b | 9.4b |

## Accounts Receivable | 21.7b | 23.7b |

## Inventories | 45.3b | 49.0b |

## Current Assets | 79.8b | 84.3b |

## PP&E | 13.3b | 12.7b |

## Goodwill | 2.3b | 1.9b |

## Total Assets | 107.8b | 114.4b |

## Accounts Payable | 18.7b | 21.5b |

## Short-term debt | 9.4b | 10.8b |

## Current Liabilities | 47.5b | 55.0b |

## Long-term debt | 16.6b | 10.1b |

## Non-Current Liabilities | 28.3b | 20.9b |

## Total Debt | 26.0b | 20.9b |

## Total Liabilities | 75.8b | 75.9b |

## Common Stock | 10.0b | 10.0b |

## Additional Paid-in Capital | 9.4b | 9.9b |

## Retained Earnings | 12.9b | 18.8b |

## Total Equity | 31.8b | 37.7b |

## Debt to Equity Ratio | 0.8 x | 0.6 x |

## Debt to Assets Ratio | 0.2 x | 0.2 x |

## Financial Leverage | 3.4 x | 3 x |

JPY | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|

## Net Income | 596.0m | 4.5b | 5.9b |

## Depreciation and Amortization | 2.9b | 3.0b | 2.8b |

## Accounts Receivable | (898.0m) | (3.2b) | (2.0b) |

## Inventories | 832.0m | (3.2b) | (8.0b) |

## Accounts Payable | (3.3b) | 4.4b | 1.2b |

## Cash From Operating Activities | (573.0m) | 6.5b | 4.8b |

## Purchases of PP&E | (2.5b) | (1.6b) | (1.3b) |

## Cash From Investing Activities | (1.1b) | 469.0m | (1.5b) |

## Short-term Borrowings | (4.5b) | (2.2b) | |

## Long-term Borrowings | (7.0b) | (5.4b) | (5.4b) |

## Dividends Paid | (677.0m) | (677.0m) | (873.0m) |

## Cash From Financing Activities | (289.0m) | (7.5b) | (3.7b) |

## Net Change in Cash | (2.3b) | (328.0m) | (552.0m) |

JPY | H1, 2018 | H1, 2019 |
---|---|---|

## Net Income | (731.0m) | 1.4b |

## Depreciation and Amortization | 1.3b | 1.3b |

## Accounts Receivable | 5.7b | 6.9b |

## Inventories | (5.8b) | (7.2b) |

## Accounts Payable | 35.0m | (1.5b) |

## Cash From Operating Activities | 1.4b | 3.2b |

## Purchases of PP&E | (977.0m) | (685.0m) |

## Cash From Investing Activities | 782.0m | (653.0m) |

## Short-term Borrowings | (2.3b) | (69.0m) |

## Long-term Borrowings | (2.7b) | (2.4b) |

## Dividends Paid | (338.0m) | (434.0m) |

## Cash From Financing Activities | (4.4b) | (3.1b) |

## Net Change in Cash | (1.8b) | (436.0m) |

JPY | Y, 2019 |
---|---|

## Revenue/Employee | 36.7m |

## Debt/Equity | 0.5 x |

## Debt/Assets | 0.2 x |

## Financial Leverage | 2.9 x |